Literature DB >> 23054589

Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.

T Schmidt1, H Awad, A Slowik, C Beyer, M Kipp, T Clarner.   

Abstract

The cuprizone model is a suitable animal model of de- and remyelination secondary to toxin-induced oligodendrogliopathy. From a pharmaceutical point of view, the cuprizone model is a valuable tool to study the potency of compounds which interfere with toxin-induced oligodendrocyte cell death or boost/inhibit remyelinating pathways and processes. The aim of this study was to analyze the vulnerability of neighboring white mater tracts (i.e., the fornix and cingulum) next to the midline of the corpus callosum which is the region of interest of most studies using this model. Male mice were fed cuprizone for various time periods. Different white matter areas were analyzed for myelin (anti-PLP), microglia (anti-IBA1), and astrocyte (anti-GFAP) responses by means of immunohistochemistry. Furthermore, Luxol fast blue-periodic acid Schiff stains were performed to validate loss of myelin-reactive fibers in the different regions. Cuprizone induced profound demyelination of the midline of the corpus callosum and medial parts of the cingulum that was paralleled by a significant astrocyte and microglia response. In contrast, lateral parts of the corpus callosum and the cingulum, as well as the fornix region which is just beneath the midline of the corpus callosum appeared to be resistant to cuprizone exposure. Furthermore, resistant areas displayed reduced astrogliosis and microgliosis. This study clearly demonstrates that neighboring white matter tracts display distinct vulnerability to toxin-induced demyelination. This important finding has direct relevance for evaluation strategies in this frequently used animal model for multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054589     DOI: 10.1007/s12031-012-9896-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

1.  Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

Authors:  Elke Verena Voss; Jelena Škuljec; Viktoria Gudi; Thomas Skripuletz; Refik Pul; Corinna Trebst; Martin Stangel
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

2.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.

Authors:  T Clarner; A Parabucki; C Beyer; M Kipp
Journal:  J Neuroendocrinol       Date:  2011-07       Impact factor: 3.627

4.  IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination.

Authors:  Zizhen Kang; Liping Liu; Roo Spangler; Charles Spear; Chenhui Wang; Muhammet Fatih Gulen; Mike Veenstra; Wenjun Ouyang; Richard M Ransohoff; Xiaoxia Li
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

5.  Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Authors:  Laura Garay; Maria Claudia Gonzalez Deniselle; Lobke Gierman; Maria Meyer; Analia Lima; Paulina Roig; Alejandro F De Nicola
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

6.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 7.  The cuprizone animal model: new insights into an old story.

Authors:  Markus Kipp; Tim Clarner; Jon Dang; Sjef Copray; Cordian Beyer
Journal:  Acta Neuropathol       Date:  2009-09-18       Impact factor: 17.088

8.  Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.

Authors:  Akvile Norkute; Andrea Hieble; Alena Braun; Sonja Johann; Tim Clarner; Werner Baumgartner; Cordian Beyer; Markus Kipp
Journal:  J Neurosci Res       Date:  2009-05-01       Impact factor: 4.164

9.  Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

Authors:  Angela Groebe; Tim Clarner; Werner Baumgartner; Jon Dang; Cordian Beyer; Markus Kipp
Journal:  Cerebellum       Date:  2009-03-04       Impact factor: 3.847

10.  Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.

Authors:  Wolfgang Brück; Ramona Pförtner; Trinh Pham; Jingya Zhang; Liat Hayardeny; Victor Piryatinsky; Uwe-Karsten Hanisch; Tommy Regen; Denise van Rossum; Lars Brakelmann; Karin Hagemeier; Tanja Kuhlmann; Christine Stadelmann; Gareth R John; Nadine Kramann; Christiane Wegner
Journal:  Acta Neuropathol       Date:  2012-07-06       Impact factor: 17.088

View more
  20 in total

1.  Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor β ligand-induced remyelination in a mouse model of multiple sclerosis.

Authors:  Kelley C Atkinson; Jeong Bin Lee; Jonathan P C Hasselmann; Sung Hoon Kim; Alyson Drew; Joselyn Soto; John A Katzenellenbogen; Neil G Harris; Andre Obenaus; Seema K Tiwari-Woodruff
Journal:  Neurobiol Dis       Date:  2019-06-18       Impact factor: 5.996

2.  Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.

Authors:  Alexandra Taraboletti; Tia Walker; Robin Avila; He Huang; Joel Caporoso; Erendra Manandhar; Thomas C Leeper; David A Modarelli; Satish Medicetty; Leah P Shriver
Journal:  Biochemistry       Date:  2017-02-28       Impact factor: 3.162

3.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

4.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

5.  Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination.

Authors:  Davood Zarini; Parichehr Pasbakhsh; Maryam Shabani; Sina Mojaverrostami; Maedeh Hashemi; Shiva Amirizadeh; Jamal Majidpoor; Ameneh Omidi; Keywan Mortezaee; Iraj Ragerdi Kashani
Journal:  Neurotox Res       Date:  2022-09-02       Impact factor: 3.978

6.  Evaluation strategy to determine reliable demyelination in the cuprizone model.

Authors:  Uta Chrzanowski; Christoph Schmitz; Anja Horn-Bochtler; Anne Nack; Markus Kipp
Journal:  Metab Brain Dis       Date:  2019-01-03       Impact factor: 3.584

7.  Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination.

Authors:  Maria F Falangola; David N Guilfoyle; Ali Tabesh; Edward S Hui; Xingju Nie; Jens H Jensen; Scott V Gerum; Caixia Hu; John LaFrancois; Heather R Collins; Joseph A Helpern
Journal:  NMR Biomed       Date:  2014-06-03       Impact factor: 4.044

8.  A mouse model for testing remyelinating therapies.

Authors:  C Brian Bai; Sunny Sun; Andrew Roholt; Emily Benson; Dale Edberg; Satish Medicetty; Ranjan Dutta; Grahame Kidd; Wendy B Macklin; Bruce Trapp
Journal:  Exp Neurol       Date:  2016-07-03       Impact factor: 5.330

9.  Astroglial redistribution of aquaporin 4 during spongy degeneration in a Canavan disease mouse model.

Authors:  Tim Clarner; Nicola Wieczorek; Barbara Krauspe; Katharina Jansen; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2013-11-24       Impact factor: 3.444

Review 10.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.